The Mystery Of Russia’s COVID-19 Vaccine
Reports Differ Over Immunization Program & Manufacturing
Russia may have approved the first COVID-19 vaccine, but there is uncertainty over when immunization will begin, who will receive it first, and whether the Russian authorities are planning to carry out Phase III trials.
You may also be interested in...
Convalescent plasma has taken another battering as a potential treatment for coronavirus patients, after a UK drug safety body agreed with a US expert panel that there was not yet enough evidence to recommend its use in COVID-19 patients.
The UK has been stepping up its COVID-19 activity in recent days, ordering more vaccines, encouraging more volunteers to join clinical trials, and expanding its RECOVERY platform for potential new coronavirus therapies. But the government's sudden decision to replace Public Health England with a new institute has raised some concerns within the biopharma industry.
The UK medicines regulator has a “unique opportunity” to evaluate the systems it operates and to “do things differently", according to its long-term interim head, June Raine.